Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-30 22:22:36 - browse：2382

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Naloxone nonprofit donates 200,000 doses after FDA approval

WSS

Paying for Covid pills will soon shift to insurers

Drastic changes should bring profitability, startup health insurers say

The pink breast cancer awareness ribbon needs a redesign

Readout Newsletter: What happened with Sarepta's Duchenne data

NIH trials fail to test meaningful long Covid therapies, experts say

Naloxone nonprofit donates 200,000 doses after FDA approval

knowledge

Wikipedia

Sign up for D.C. Diagnosis

explore

23andMe had bad news about my health. I wish a person had delivered it

Friends ask where James Watson's attitudes about race came from

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Naloxone nonprofit donates 200,000 doses after FDA approval

Malaria cases in Florida and Texas: Here’s what you need to know

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Walensky prepares to leave CDC — and Congress — behind

Senate panel to vote on hospitals, PBMs, prisoner care

State Dept. review finds Biden bears some blame for Afghanistan failures

The pink breast cancer awareness ribbon needs a redesign

entertainment

Maker of FluMist seeks to allow at

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Telehealth options flood the market as retailers push virtual care

A biotech analyst on neuroscience, placebo effect, not over

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Maui's cultural, historic landmarks damaged in the devastating wildfires

leisure time

hotspot

Wikipedia

explore